Skip to main content
Get Alerts

Data Explorer

Research historical outbreak investigations and the full recall archive, with charts, trends, and advanced filters. Looking for what's happening right now instead? See current Health Alerts.

Recall totals

All FDA and USDA recalls in Public Health Trace, June 2012 to October 2026.

37,238
Total recall recordsAll FDA and USDA recalls in Public Health Trace
9,844
Class I recallsReasonable probability of serious health consequences
24,383
Class II recallsTemporary or medically reversible health consequences
2,897
Class III recallsNot likely to cause adverse health consequences

Quick insights

A snapshot of the most notable patterns across all recorded FDA and USDA recalls.

Most recalled product100 vegetarian Fenugreek Capsules 90 count, 600mg, packaged in 150cc Amber Glass Packer with White Polypropylene Cap. 53 recalls
Most common hazardLack of Assurance of Sterility 2,084 recalls
Newest recallhttps://www.fsis.usda.gov/recalls-alerts/fsis-issues-public-health-alert-ineligible-chicken-vienna-style-sausage-productsPublished October 6, 2026
Most affected stateHawaii 200 recalls mention this state

Download matching recalls as CSV

CSV exports include up to 5,000 matching rows (applying your current filters), not the full dataset if it's larger.

Filters
Recall details
Location
Date range
Sort results
Clear filters
Metric
View
Recalls announced by month (Year to date)

A chart of recalls grouped by month.

Download CSV

Source: FDA and USDA public dataLast updated

Summary (Year to date)

  • 1,739 recalls have been announced year to date.
  • Sep 2026 was 15% higher than the previous complete period (Aug 2026: 182).
  • The highest complete period was Jun 2026 (300).
  • Oct 2026 is incomplete and not included in the figures above.
  • Complete data
  • Incomplete
Recalls by class

A bar chart of the total number of recalls in this dataset by recall class.

Recalls by class
ClassRecalls
Class II24,383
Class I9,844
Class III2,897
Not Yet Classified2
Download CSV
Recalls by class
ClassRecalls
Class II24,383
Class I9,844
Class III2,897
Not Yet Classified2

Showing 19,461–19,480 of 20,461 recalls

FDA Recall TerminatedTerminated: March 19, 2014Historical recordClass II

Ranitidine Hydrochloride Tablets, USP, 150 mg, OTC, a) Equate brand Maximum Strength Acid Reducer, 65 count bottle Dist. By: Wal-Mart Stores, Inc., Bentonville, AR 72710, NDC 49035-404-61 b)Equaline brand maximum strength heartburn relief, , DISTRIBUTED BY SUPERVALU INC., EDEN PRAIRIE, MN 55344, NDC 41163-404-61, c)Wal-Zan brand 150, MAXIMUM STRENGTH, 24 count bottlle, DISTRIBUTED BY: WALGREEN CO., 200 WILMOT RD., DEERFIELD, IL 63015, NDC 0363-0404-34

by Dr. Reddy's Laboratories, Inc.

Reason
Microbial Contamination of Non-Sterile Products: A lot of raw material used in the manufacture of Ranitidine was positive for Pseudomonas sp.
Published
August 21, 2013
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: June 23, 2014Historical recordClass II

Belladonna Alkaloids with Phenobarbital Tablets, 1000 count (NDC 0143-1140-10) and 5000 count (NDC 0143-1140-51) PET bottles, Rx Only, Manufactured by West-ward Pharmaceutical Corp., Eatontown, N.J., 07724.

by West-Ward Pharmaceutical Corp.

Reason
Presence of Foreign Substance: black specks comprised of degraded organic material found on tablets
Published
August 21, 2013
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: June 23, 2014Historical recordClass III

Prednisone Tablet USP, 20 mg tablets, packaged in blisters of ten (10) tablets per blister card, ten blister cards per carton, Roxanne, Columbus, OH --- NDC 0054-0018-20

by Boehringer Ingelheim Roxane Inc

Reason
Labeling: Missing Label; missing label on blister card
Published
August 21, 2013
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: August 21, 2013Historical recordClass II

Verapamil Injection, compounded by Pallimed Solutions Pharmacy, Woburn, MA

by Pallimed Solutions

Reason
Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurance
Published
August 21, 2013
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: August 21, 2013Historical recordClass II

Vancomycin Ophthalmic PF, compounded by Pallimed Solutions Pharmacy, Wobrun, MA

by Pallimed Solutions

Reason
Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurance
Published
August 21, 2013
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: August 21, 2013Historical recordClass II

Trimix Injection, compounded by Pallimed Solutions Pharmacy, Woburn, MA

by Pallimed Solutions

Reason
Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurance
Published
August 21, 2013
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: August 21, 2013Historical recordClass II

Testosterone Cypionate Injection,compounded by Pallimed Solutions Pharmacy, Woburn, MA

by Pallimed Solutions

Reason
Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurance
Published
August 21, 2013
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: August 21, 2013Historical recordClass II

Testosterone Cypionate/Propionate Injection, compounded by Pallimed Solutions Pharmacy, Woburn, MA

by Pallimed Solutions

Reason
Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurance
Published
August 21, 2013
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: August 21, 2013Historical recordClass II

Testosterone Cypionate/Testosterone Enanthate Injection, compounded by Pallimed Solutions Pharmacy, Woburn, MA

by Pallimed Solutions

Reason
Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurance
Published
August 21, 2013
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: August 21, 2013Historical recordClass II

Tacrolimus Ophthalmic, Pallimed Solutions Pharmacy, Woburn, MA

by Pallimed Solutions

Reason
Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurance
Published
August 21, 2013
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: August 21, 2013Historical recordClass II

Quadmix Injection, compounded by Pallimed Solutions Pharmacy, Woburn, MA

by Pallimed Solutions

Reason
Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurance
Published
August 21, 2013
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: August 21, 2013Historical recordClass II

Nandrolone Decanoate Injectable, compounded by Pallimed Solutions Pharmacy, Woburn, MA

by Pallimed Solutions

Reason
Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurance
Published
August 21, 2013
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: August 21, 2013Historical recordClass II

MIC with B6 and B12, compounded by Pallimed Solutions Pharmacy, Woburn, MA

by Pallimed Solutions

Reason
Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurance
Published
August 21, 2013
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: August 21, 2013Historical recordClass II

Methylcobalamin PF, compounded by Pallimed Solutions Pharmacy, Woburn, MA

by Pallimed Solutions

Reason
Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurance
Published
August 21, 2013
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: August 21, 2013Historical recordClass II

Hydroxyprogesterone CAPR.(G.S.), compounded by Pallimed Solutions Pharmacy, Woburn MA

by Pallimed Solutions

Reason
Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurance
Published
August 21, 2013
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: August 21, 2013Historical recordClass II

HCG Chorionic Gonadotropin, compounded by Pallimed Solutions Pharmacy, Woburn, MA

by Pallimed Solutions

Reason
Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurance
Published
August 21, 2013
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: August 21, 2013Historical recordClass II

Gentamicin Sulfate Irrigation, compounded by Pallimed Solutions Pharmacy, Woburn, MA

by Pallimed Solutions

Reason
Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurance
Published
August 21, 2013
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: August 21, 2013Historical recordClass II

DMSO Aqueous Irrigation 50%, compounded by Pallimed Solutions Pharmacy, Woburn, MA

by Pallimed Solutions

Reason
Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurance
Published
August 21, 2013
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: August 21, 2013Historical recordClass II

Dexamethasone PF, compounded by Pallimed Solutions Pharmacy, Woburn, MA

by Pallimed Solutions

Reason
Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurance
Published
August 21, 2013
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: August 21, 2013Historical recordClass II

Diazepam Injectable, compounded by Pallimed Solutions Pharmacy, Woburn, MA

by Pallimed Solutions

Reason
Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurance
Published
August 21, 2013
Distribution
Nationwide

View recall →

Data last updated:

Recall records are summarized from official FDA and USDA sources. Notices may be updated, reclassified, terminated, or withdrawn. Always review the linked official notice for the most current instructions. Read the full medical disclaimer.